Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ritesh Agarwal and Inderpaul Sehgal.
Ritesh Agarwal
Connection Strength
2.626
Inderpaul Sehgal
  1. A randomised trial of Mycobacterium w in critically ill patients with COVID-19: ARMY-1. ERJ Open Res. 2021 Apr; 7(2).
    View in: PubMed
    Score: 0.939
  2. Safety of an immunomodulator Mycobacterium w in COVID-19. Lung India. 2020 May-Jun; 37(3):279-281.
    View in: PubMed
    Score: 0.880
  3. Is high-dose glucocorticoid beneficial in COVID-19? Eur Respir J. 2021 04; 57(4).
    View in: PubMed
    Score: 0.235
  4. Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature. Mycopathologia. 2021 May; 186(2):289-298.
    View in: PubMed
    Score: 0.232
  5. Transforming a General Hospital to an Infectious Disease Hospital for COVID-19 Over 2 Weeks. Front Public Health. 2020; 8:382.
    View in: PubMed
    Score: 0.224
  6. Conventional flexible bronchoscopy during the COVID pandemic: A consensus statement from the Indian Association for Bronchology. Lung India. 2021 Mar; 38(Supplement):S105-S115.
    View in: PubMed
    Score: 0.058
  7. Multidimensional dynamic healthcare personnel (HCP)-centric model from a low-income and middle-income country to support and protect COVID-19 warriors: a large prospective cohort study. BMJ Open. 2021 02 22; 11(2):e043837.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.